Literature DB >> 12433892

Widespread cardiovascular autonomic dysfunction in primary amyloidosis: does spontaneous hyperventilation have a compensatory role against postural hypotension?

L Bernardi1, C Passino, C Porta, E Anesi, G Palladini, G Merlini.   

Abstract

OBJECTIVE: To investigate the possible causes of abnormal blood pressure control in light chain related (primary, AL) amyloidosis.
DESIGN: Cardiovascular, autonomic, and respiratory response to passive tilting were investigated in 51 patients with primary amyloidosis (mean (SEM) age 56 (2) years) and in 20 age matched controls. Spontaneous fluctuations in RR interval, respiration, end tidal carbon dioxide, blood pressure, and skin microcirculation were recorded during supine rest and with tilting. The values were subjected to spectral analysis to assess baroreflex sensitivity and the autonomic modulation of cardiac and vascular responses.
SETTING: Tertiary referral centre.
RESULTS: Autonomic modulation of the heart and blood pressure was nearly absent in the patients with amyloidosis: thus baroreflex sensitivity and the low frequency (0.1 Hz) fluctuations in all cardiovascular signals were severely reduced (p < 0.01 or more), as were respiratory fluctuations in the RR interval, and no change was observed upon tilting. Despite reduced autonomic modulation, blood pressure remained relatively stable in the amyloid group from supine to tilting. End tidal carbon dioxide was reduced in the amyloid patients (p < 0.001) indicating persistent hyperventilation; the breathing rate correlated inversely with the fall in blood pressure on tilting (p < 0.05).
CONCLUSIONS: In primary amyloidosis, pronounced abnormalities in arterial baroreflexes and cardiovascular autonomic modulation to the heart and the vessels may be partly compensated for by hyperventilation at a slow breathing rate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12433892      PMCID: PMC1767452          DOI: 10.1136/heart.88.6.615

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  26 in total

Review 1.  Autonomic dysfunction in familial amyloidotic polyneuropathy (FAP).

Authors:  Y Ando; O B Suhr
Journal:  Amyloid       Date:  1998-12       Impact factor: 7.141

2.  Spectral and cross-spectral analysis of heart rate and arterial blood pressure variability signals.

Authors:  G Baselli; S Cerutti; S Civardi; D Liberati; F Lombardi; A Malliani; M Pagani
Journal:  Comput Biomed Res       Date:  1986-12

3.  Peripheral catecholamine depletion in amyloid autonomic neuropathy.

Authors:  A E Rubenstein; M D Yahr; C Mytilineou; K Bajaj
Journal:  Mt Sinai J Med       Date:  1978 Nov-Dec

4.  Decreased sympathetic vasomotor tone in diabetic orthostatic hypotension.

Authors:  J Hilsted
Journal:  Diabetes       Date:  1979-11       Impact factor: 9.461

5.  Differences in circulatory control in normal subjects who faint and who do not faint during orthostatic stress.

Authors:  A D ten Harkel; J J van Lieshout; J M Karemaker; W Wieling
Journal:  Clin Auton Res       Date:  1993-04       Impact factor: 4.435

6.  Effects of respiratory apparatus on breathing pattern.

Authors:  J Askanazi; P A Silverberg; R J Foster; A I Hyman; J Milic-Emili; J M Kinney
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1980-04

7.  Physical manoeuvres for combating orthostatic dizziness in autonomic failure.

Authors:  J J van Lieshout; A D ten Harkel; W Wieling
Journal:  Lancet       Date:  1992-04-11       Impact factor: 79.321

8.  Catecholamine metabolism in familial amyloid polyneuropathy.

Authors:  T Suzuki; I Tsuge; S Higa; A Hayashi; Y Yamamura; Y Takaba; A Nakajima
Journal:  Clin Genet       Date:  1979-08       Impact factor: 4.438

9.  Changes in autonomic regulation induced by physical training in mild hypertension.

Authors:  M Pagani; V Somers; R Furlan; S Dell'Orto; J Conway; G Baselli; S Cerutti; P Sleight; A Malliani
Journal:  Hypertension       Date:  1988-12       Impact factor: 10.190

10.  Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension.

Authors:  G Grassi; C Giannattasio; J Cléroux; C Cuspidi; L Sampieri; G B Bolla; G Mancia
Journal:  Hypertension       Date:  1988-09       Impact factor: 10.190

View more
  9 in total

1.  Coexistence of cardiac amyloidosis with coronary artery disease and the challenges in medical management.

Authors:  Vasvi Singh; Alexander Tiemeier; Saurabh Malhotra
Journal:  J Nucl Cardiol       Date:  2019-02-20       Impact factor: 5.952

Review 2.  New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis.

Authors:  Stefano Perlini; Roberta Mussinelli; Francesco Salinaro
Journal:  Curr Heart Fail Rep       Date:  2016-12

3.  Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis.

Authors:  Sharmila Dorbala; Divya Vangala; John Bruyere; Christina Quarta; Jenna Kruger; Robert Padera; Courtney Foster; Michael Hanley; Marcelo F Di Carli; Rodney Falk
Journal:  JACC Heart Fail       Date:  2014-07-09       Impact factor: 12.035

4.  What Happens before Syncope? Study of the Time Frame Preceding Vasovagal Syncope.

Authors:  Alfonso Lagi; Simone Cencetti; Alessandro Cartei
Journal:  ISRN Cardiol       Date:  2011-04-14

Review 5.  Novel Therapies in Light Chain Amyloidosis.

Authors:  Paolo Milani; Giampaolo Merlini; Giovanni Palladini
Journal:  Kidney Int Rep       Date:  2017-11-28

Review 6.  Light Chain Amyloidosis.

Authors:  Paolo Milani; Giampaolo Merlini; Giovanni Palladini
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-03-01       Impact factor: 2.576

7.  Reactive Vasodilation Predicts Mortality in Primary Systemic Light-Chain Amyloidosis.

Authors:  Kimon Stamatelopoulos; Georgios Georgiopoulos; Fani Athanasouli; Panagiota-Efstathia Nikolaou; Marita Lykka; Maria Roussou; Maria Gavriatopoulou; Aggeliki Laina; Georgia Trakada; Marietta Charakida; Dimitris Delialis; Ioannis Petropoulos; Constantinos Pamboukas; Efstathios Manios; Marina Karakitsou; Christos Papamichael; Aikaterini Gatsiou; Irene Lambrinoudaki; Evangelos Terpos; Konstantinos Stellos; Ioanna Andreadou; Meletios A Dimopoulos; Efstathios Kastritis
Journal:  Circ Res       Date:  2019-08-12       Impact factor: 17.367

8.  Diagnosis and treatment of cardiac amyloidosis: an interdisciplinary consensus statement.

Authors:  Diana Bonderman; Gerhard Pölzl; Klemens Ablasser; Hermine Agis; Stefan Aschauer; Michaela Auer-Grumbach; Christina Binder; Jakob Dörler; Franz Duca; Christian Ebner; Marcus Hacker; Renate Kain; Andreas Kammerlander; Matthias Koschutnik; Alexander Stephan Kroiss; Agnes Mayr; Christian Nitsche; Peter P Rainer; Susanne Reiter-Malmqvist; Matthias Schneider; Roland Schwarz; Nicolas Verheyen; Thomas Weber; Marc Michael Zaruba; Roza Badr Eslam; Martin Hülsmann; Julia Mascherbauer
Journal:  Wien Klin Wochenschr       Date:  2020-12-03       Impact factor: 1.704

Review 9.  Biomarkers in AL Amyloidosis.

Authors:  Despina Fotiou; Foteini Theodorakakou; Efstathios Kastritis
Journal:  Int J Mol Sci       Date:  2021-10-09       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.